Calibre Scientific has announced its acquisition of AlphaScience GmbH, a diagnostics provider with its headquarters in Frankfurt, Germany.
AlphaScience will be integrated with BIOZOL Diagnostica GmbH, a subsidiary of Calibre Scientific. With this acquisition, BIOZOL further enhances its position in the German research and diagnostics market, as AlphaScience brings new supplier relationships and product expertise that complement BIOZOL’s capabilities. Terms of the deal were not disclosed.
AlphaScience is a provider of consumables and equipment for the commercial lab, clinical lab, academic, research and hospital industries. The company’s diagnostics product portfolio covers end-market applications, including autoimmune, allergy, clinical chemistry, infectious disease, general lab supplies, molecular diagnostics and reagents.
Calibre Scientific is a global provider of life science reagents, tools, instruments and other consumables to the lab research, diagnostics, industrial and biopharmaceutical communities. Calibre Scientific owns a portfolio of 25 life science and diagnostic companies. Through a combination of acquisitions and organic growth, its global reach extends to more than 175 countries.
This marks Calibre Scientific’s second transaction of 2023. In January, the company acquired Glass Chemicals, which markets and distributes products for laboratory, hospital and pharmaceutical customers, for an undisclosed price.
According to data captured in the LevinPro HC database, this acquisition represents the 30th Laboratories, MRI and Dialysis transaction of 2023 and the 15th in the diagnostics subsector. There were 31 Laboratories, MRI and Dialysis deals, including 25 diagnostics acquisitions, announced between January 1, 2022, and March 15, 2022.
